Skip to main content
SpringerLink
Log in

The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophrenia

  • Review
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract.

Neuropsychological deficits seem to be a major predictor of psychosocial outcome in patients with schizophrenia. Second-generation antipsychotics have shown greater promise in treating neuropsychological deficits than conventional antipsychotic drugs. This article summarizes the effect of newer antipsychotics on cognitive functioning and the implications for functional outcome. In this context it also addresses several methodological and conceptional issues that limited the comparison of these studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Biological Psychiatry, Innsbruck University Clinics, Anichstrasse 35, 6020 Innsbruck, Austria, Austria

    Elisabeth M. Weiss & Wolfgang W. Fleischhacker

  2. Nathan S. Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY 10962, USA, USA

    Robert M. Bilder

Authors
  1. Elisabeth M. Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert M. Bilder
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wolfgang W. Fleischhacker
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Electronic Publication

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weiss, E.M., Bilder, R.M. & Fleischhacker, W.W. The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophrenia. Psychopharmacology 162, 11–17 (2002). https://doi.org/10.1007/s00213-002-1053-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-002-1053-y

Search

Navigation